Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following Descemet's Membrane Endothelial Keratoplasty Using Ultra-high Resolution Optical Coherence Tomography
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- Area of attached graft after DMEK
研究概览
简要总结
Fuchs endothelial corneal dystrophy (FECD) is a progressive disease characterized by the loss of endothelial cells, thickening of Descemet's membrane and deposition of extracellular matrix in the form of guttae. This result in failure of the endothelium to support corneal deturgescence leading to corneal edema. Affected patients complain about blurred vision at early stages of the disease which can progress to blindness. The pathophysiology of the disease is still unclear, but several studies point towards a genetic susceptibility. Additional risk factors that have been identified are female sex, smoking and older age.
While for a long time penetrating keratoplasty (PKP) was the only therapy available for affected patients, in the recent years less invasive methods such as descemet's membrane endothelial keratoplasty (DMEK) have been developed. In DMEK, only the Descemet's membrane and the endothelium is removed and replaced with the corresponding parts from a donor's cornea. For FECD, this brings the advantage that only the diseased part of the cornea is replaced. Graft detachment has been identified as the main complication following DMEK.
In the investigators' study, an ultra high resolution OCT system will be used to detect graft detachment in patients with FECD after DMEK. With this technique, even small detachments can be visualized. The area of graft detachment will be evaluated at predefined time points after surgery and correlated to visual acuity. A follow-up of one year will be performed in order to investigate the predictive value of graft adherence status at several time points for visual outcome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 98 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women aged over 18 years scheduled for primary DMEK because of Fuchs' Endothelial Dystrophy
排除标准
- •Any disease inhibiting OCT acquisition; such as blepharospasm, severe tremor or immobility
- •Any previous intraocular surgery other than cataract extraction
- •Previous clinically significant ocular trauma in the study eye, as judged by the investigator
- •Pregnancy, planed pregnancy, or lactating
- •Appointment of a custodian
- •Progressive retinal disease
- •History or presence of glaucoma
研究组 & 干预措施
Patients with Fuchs endothelial dystrophy scheduled for DMEK
干预措施: Ultrahigh resolution Spectral Domain OCT (Device)
结局指标
主要结局
Area of attached graft after DMEK
时间窗: 12 months after DMEK
Change in best corrected visual acuity at 12 months compared to baseline using a standardized protocol with the Early Treatment Diabetic Retinopathy (ETDRS) charts (4 meters).
时间窗: 1-2 days, 1 week, 1 month, 6 months and 12 months after DMEK
Visual acuity will be measured using a standardized protocol with the Early Treatment Diabetic Retinopathy (ETDRS) charts (4 meters).
次要结局
- Corneal endothelial cell count(12 months)
- Number of patients in which rebubbling has to be performed(12 months)
- Number of patients needing retreatment(12 months)
- Best corrected visual acuity at 6 months using a standardized protocol with the Early Treatment Diabetic Retinopathy (ETDRS) charts (4 meters).(6 months)
- Demographic risk factors such as age(12 months)
- Demographic risk factors such as gender(12 months)
- Demographic risk factors, such as family history(12 months)
- Demographic risk factors, such as smoking status(12 months)
- Central corneal thickness(12 months)
研究者
Gerhard Garhofer
Assoc. Prof. PD Dr.
Medical University of Vienna
